Elsevier

Urology

Volume 46, Issue 3, September 1995, Pages 352-355
Urology

Open pelvic lymph node dissection for prostate cancer: a reassessment

https://doi.org/10.1016/S0090-4295(99)80219-2Get rights and content

Abstract

Objectives

To provide a risk-to-benefit analysis of open staging pelvic lymph node dissection (PLND) for prostate cancer.

Methods

The medical records of all patients presenting with prostate cancer from July 1989 to April 1994 were reviewed. A total of 245 patients with clinically localized disease were selected to undergo radical retropubic prostatectomy (RRP) preceded by open PLND. Univariate and multivariate analyses were performed to evaluate the predictive value of the preoperative serum prostate-specific antigen (PSA) concentration, clinical stage, and Cleason score with regard to final nodal status. The cost and morbidity associated with PLND in the setting of RRP was also defined.

Results

Overall, only 16 patients (6.5%) had lymph node metastases. Lymph node involvement correlated significantly with elevated serum PSA values (P = 0.0001), high Gleason score (P = 0.0022), and advanced clinical stage (P = 0.0001). Lymph node metastases were particularly uncommon in patients with nonpalpable tumors (1 of 67 [1.5%]), PSA values less than 10 (2 of 154 [1.3%]), and Gleason score less than 6 (1 of 26 [3.8%]). Overall, 179 patients (73.1 %) presented with at least one or more of these favorable characteristics, and only 4 (2.2%) had lymph node involvement. Complications related to the lymphadenectomy occurred in 10 patients (4.1%). The cost per metastasis diagnosed in patients with low-risk characteristics was approximately $43,600.

Conclusions

An open staging PLND may no longer be justified on a routine basis in patients undergoing radical retropubic prostatectomy.

References (22)

Cited by (77)

  • Appearance of primary lymphoid malignancies on lymphotropic nanoparticle-enhanced magnetic resonance imaging using ferumoxtran-10

    2010, Clinical Imaging
    Citation Excerpt :

    In the third patient with prostate cancer, the extensiveness of the lymphadenopathy was out of proportion to what was expected based on tumor grade and prostate-specific antigen (PSA) level. Previous studies have shown that nodal metastases in prostate cancer are usually not seen until the Gleason score is over 6 and the blood PSA level is over 10 [9]. This patient had extensive malignant lymphadenopathy in the left external, bilateral obturator, bilateral common iliac, and paraaortic regions, despite a Gleason score of 6 and a PSA of 7.4.

  • The Use of a Surgical Patch in the Prevention of Lymphoceles After Extraperitoneal Pelvic Lymphadenectomy for Prostate Cancer: A Randomized Prospective Pilot Study

    2009, Journal of Urology
    Citation Excerpt :

    In the studies that may be found in the literature there is a low lymphocele rate. However, the number of lymph nodes removed during radical prostatectomy may vary greatly and, thus, so does the rate of complications that may be found in a retrospective study but not in a controlled prospective one.3–5,13,14 We believe that you find what you look for.

View all citing articles on Scopus
View full text